Customized Lanthanide Nanobiohybrids for Noninvasive Precise Phototheranostics of Pulmonary Biofilm Infection.
Zhuo LiShan LuWenzhen LiuZhuo ChenYunmei HuangXingjun LiJiacheng GongXueyuan ChenPublished in: ACS nano (2024)
A noninvasive strategy for in situ diagnosis and precise treatment of bacterial biofilm infections is highly anticipated but still a great challenge. Currently, no in vivo biofilm-targeted theranostic agent is available. Herein, we fabricated intelligent theranostic alginate lyase (Aly)-NaNdF 4 nanohybrids with a 220 nm sunflower-like structure (NaNdF 4 @DMS-Aly) through an enrichment-encapsulating strategy, which exhibited excellent photothermal conversion efficiency and the second near-infrared (NIR-II) luminescence. Benefiting from the site-specific targeting and biofilm-responsive Aly release from NaNdF 4 @DMS-Aly, we not only enabled noninvasive diagnosis but also realized Aly-photothermal synergistic therapy and real-time evaluation of therapeutic effect in mice models with Pseudomonas aeruginosa biofilm-induced pulmonary infection. Furthermore, such nanobiohybrids with a sheddable siliceous shell are capable of delaying the NaNdF 4 dissolution and biodegradation upon accomplishing the therapy, which is highly beneficial for the biosafety of theranostic agents.
Keyphrases
- pseudomonas aeruginosa
- photodynamic therapy
- cancer therapy
- biofilm formation
- staphylococcus aureus
- candida albicans
- cystic fibrosis
- fluorescence imaging
- acinetobacter baumannii
- drug delivery
- pulmonary hypertension
- drug release
- oxidative stress
- diabetic rats
- combination therapy
- escherichia coli
- drug resistant
- drug induced
- skeletal muscle
- wound healing